Hepatology July Table of Contents 

|

Comments from the Editors

HEPATOLOGY: A home for hepatocellular cancer publications

Editorial

Alternative pathway therapy for hyperammonemia in liver failure

Viral Hepatitis

Statins potentiate the in vitro anti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance development

PCSK9 impedes hepatitis C virus infection in vitro and modulates liver CD81 expression

Mutations in the hepatitis C virus polymerase that increase RNA binding can confer resistance to cyclosporine A

Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cells

Liver Biology/Pathogiology

Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis

Steatohepatitis/Metabolic Liver Disease

Nutritional model of steatohepatitis and metabolic syndrome in the Ossabaw miniature swine

Independent effects of physical activity in patients with nonalcoholic fatty liver disease

Apolipoprotein B100 acts as a molecular link between lipid-induced endoplasmic reticulum stress and hepatic insulin resistance

Inhibiting glycosphingolipid synthesis ameliorates hepatic steatosis in obese mice

HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis-related morbidity

Hepatobiliary Malignancies

Targeting heat shock protein 90 with non-quinone inhibitors: A novel chemotherapeutic approach in human hepatocellular carcinoma

MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells

Liver Biology/Pathogiology

Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like (CHD1l) gene suppresses the nucleus-to-mitochondria translocation of nur77 to sustain hepatocellular carcinoma cell survival

Autoimmune, Cholestatic and Biliary Disease

Vigorous activation of monocytes in juvenile autoimmune liver disease escapes the control of regulatory T-cells

Bile salt-phospholipid conjugate ursodeoxycholyl lysophosphatidylethanolamide as a hepatoprotective agent

Liver Failure/Cirrhosis/Portal Hypertension

L-ornithine and phenylacetate synergistically produce sustained reduction in ammonia and brain water in cirrhotic rats

L-ornithine phenylacetate attenuates increased arterial and extracellular brain ammonia and prevents intracranial hypertension in pigs with acute liver failure

Association between dietary nutrient composition and the incidence of cirrhosis or liver cancer in the united states population

CCR2 promotes hepatic fibrosis in mice

Liver Injury/Regeneration

Toll-like receptor 3 signaling attenuates liver regeneration

p21 is required for dextrose-mediated inhibition of mouse liver regeneration

Hepatobiliary Malignanices

S6K1 deficiency protects against apoptosis in hepatocytes

Liver Biology/Pathobiology

The etiology of liver damage imparts cytokines transforming growth factor  1 or interleukin-13 as driving forces in fibrogenesis

Diferentially expressed adenylyl cyclase isoforms mediate secretory functions in cholangiocyte subpopulation

Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis

Single nucleotide polymorphism-mediated translational suppression of endoplasmic reticulum mannosidase I modifies the onset of end-stage liver disease in alpha1-antitrypsin deficiency

Protein or amino acid deprivation differentially regulates the hepatic forkhead box protein A (FOXA) genes through an activating transcription factor-4-independent pathway

AASLD Practice Guidelines

Primary biliary cirrhosis

AASLD Public Policy

Health disparities in liver disease: Time to take notice and take action

Image of the Month

Albinism, cyclic neutropenia, and ceroid pigment in the liver

Hepatology Elsewhere

Things that go BMP in the liver: Bone morphogenetic protein 6 and the control of body iron homeostasis

Correspondence

Mesenchymal origin of hepatic stellate cells, submesothelial cells, and perivascular mesenchymal cells during mouse liver development

Reply

Orlistat for overweight subjects with nonalcoholic steatohepatitis

Reply

Diagnosis, management, and treatment of hepatitis C

Management of patients with hepatitis C virus genotype 2 or 3: Comments on updated american association for the study of liver diseases practice guidelines

Comment on the updated AASLD practice guidelines for the diagnosis, management, and treatment of hepatitis C: Treating active drug users

Reply

Serum Golgi Phosphoprotein 2 level: A better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma

Alpha-fetoprotein and serum golgi phosphoprotein 2 are equally discriminative in detecting early hepatocellular carcinomas

Adipocytokine levels in nonalcoholic fatty liver disease

Reply

Utility of magnetic resonance imaging in the evaluation of hepatic fat content

Reply

Screening for Wilson's disease in acute liver failure: A comparison of currently available diagnostic tests

Interleukin-17-targeted treatment of alcoholic liver disease

Corrections

Correction

Correction